Erika Durinikova

Bratislava, BL 84505, Slovakia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

Journal: EMBO molecular medicine

Published: September 30, 2025

Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells.

Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells.

Journal: Cell reports. Medicine

Published: April 16, 2023

Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer.

Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 18, 2022

Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived Organoids.

Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived Organoids.

Journal: JCO precision oncology

Published: April 07, 2021

Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.

Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 06, 2021

Development of LC-HRMS methods for evaluation of metabolic conversion of 5-fluorocytosine at GDEPT procedure.

Development of LC-HRMS methods for evaluation of metabolic conversion of 5-fluorocytosine at GDEPT procedure.

Journal: Journal of pharmaceutical and biomedical analysis

Published: August 14, 2020

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness.

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness.

Journal: Cancer cell international

Published: May 05, 2020

Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.

Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.

Journal: Biochemical pharmacology

Published: September 12, 2019

A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.

A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 24, 2019

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells.

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells.

Journal: Cancers

Published: July 02, 2019

Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells.

Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells.

Journal: Cell death & disease

Published: November 08, 2018

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer.

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 20, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026